Literature DB >> 9670854

HLA associations with multiple sclerosis in the Canary Islands.

F Coraddu1, M P Reyes-Yanez, A Parra, J Gray, S I Smith, C J Taylor, D A Compston.   

Abstract

The study of small island populations has proved informative with respect to the epidemiology and genetics of many complex traits including multiple sclerosis. The class II major histocompatibility antigen DR15 is associated with multiple sclerosis in all groups except Sardinians, where the primary association is with DR4. We compared HLA-DR and -DQ allele frequencies in a representative sample of patients with multiple sclerosis from the Canary Islands with appropriate controls. There was a significant association with DR15 (patients 21/53: 40%: controls 11/55; 20%: chi2=4.09; pc=0.04; relative risk [RR]=1.98). DRB1*1501-DRB5*0101 was present in 17/53 (32%) patients in whom sub-types could be identified compared with 6/55 (11%) controls (chi2=7.21; pc=< 0.01; RR=2.94). All DR15 positive controls carried the DQA1*0102, DQB1*0602 haplotype whereas this was only present in 26/30 patients, suggesting that the primary association is with HLA-DR and not -DQ. We also found a significant increase in HLA-DR4 (16/53 [30%] in patients compared with 7/55 [13%] in controls; pc=0.05). This study contributes a new point on the immunogenetic map of multiple sclerosis in Europe, confirming the primary DR15 association with multiple sclerosis in a previously unstudied population but again highlighting the importance of DR4 in Mediterranean peoples.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9670854     DOI: 10.1016/s0165-5728(98)00074-5

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  11 in total

Review 1.  The genetic epidemiology of multiple sclerosis.

Authors:  A Compston
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-10-29       Impact factor: 6.237

2.  HLA-DR 15 is associated with female sex and younger age at diagnosis in multiple sclerosis.

Authors:  A E Hensiek; S J Sawcer; R Feakes; J Deans; A Mander; E Akesson; R Roxburgh; F Coraddu; S Smith; D A S Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-02       Impact factor: 10.154

Review 3.  Genetic analysis of multiple sclerosis.

Authors:  Alastair Compston; Stephen Sawcer
Journal:  Curr Neurol Neurosci Rep       Date:  2002-05       Impact factor: 5.081

4.  The fine specificity of human T cell lines towards myelin basic protein peptides in southern Italian multiple sclerosis patients.

Authors:  D Montanaro; V Sanna; G Matarese; B B Larby; L Racioppi; P B Carrieri; R Bruno; N J Davey; S Zappacosta; S Fontana
Journal:  Clin Exp Immunol       Date:  2001-02       Impact factor: 4.330

5.  A second major histocompatibility complex susceptibility locus for multiple sclerosis.

Authors:  Tai Wai Yeo; Philip L De Jager; Simon G Gregory; Lisa F Barcellos; Amie Walton; An Goris; Chiara Fenoglio; Maria Ban; Craig J Taylor; Reyna S Goodman; Emily Walsh; Cara S Wolfish; Roger Horton; James Traherne; Stephan Beck; John Trowsdale; Stacy J Caillier; Adrian J Ivinson; Todd Green; Susan Pobywajlo; Eric S Lander; Margaret A Pericak-Vance; Jonathan L Haines; Mark J Daly; Jorge R Oksenberg; Stephen L Hauser; Alastair Compston; David A Hafler; John D Rioux; Stephen Sawcer
Journal:  Ann Neurol       Date:  2007-03       Impact factor: 10.422

Review 6.  The immunogenetics of multiple sclerosis.

Authors:  Arne Svejgaard
Journal:  Immunogenetics       Date:  2008-05-07       Impact factor: 2.846

Review 7.  Multiple sclerosis.

Authors:  David A Hafler
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

8.  HLA class II alleles in patients with multiple sclerosis in the Biscay province (Basque Country, Spain).

Authors:  Oscar Fernández; Alfredo R-Antigüedad; María Jesús Pinto-Medel; Mari Mar Mendibe; Nestor Acosta; Begoña Oliver; Miguel Guerrero; Marcos Papais-Alvarenga; Victoria Fernández-Sánchez; Laura Leyva
Journal:  J Neurol       Date:  2009-12       Impact factor: 4.849

9.  Influence of histocompatibility genes on disease susceptibility and treatment response in patients with relapsing-remitting multiple sclerosis treated with interferon β-1a.

Authors:  Shlomo Flechter; Tirza Klein; Lea Pollak
Journal:  Neurol Int       Date:  2011-06-15

10.  Variation of the myelin oligodendrocyte glycoprotein gene is not primarily associated with multiple sclerosis in the Sardinian population.

Authors:  Maria Giovanna Marrosu; Raffaele Murru; Gianna Costa; Maria Cristina Melis; Marcella Rolesu; Lucia Schirru; Elisabetta Solla; Stefania Cuccu; Maria Antonietta Secci; Michael B Whalen; Eleonora Cocco; Maura Pugliatti; Stefano Sotgiu; Giulio Rosati; Francesco Cucca
Journal:  BMC Genet       Date:  2007-05-17       Impact factor: 2.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.